SEC Comment Letter for SOLIGENIX, INC. (SNGX) (CIK 0000812796) (SNGX) — Oct 17, 2016
SOLIGENIX, INC. (SNGX) (CIK 0000812796)
Date: Oct. 17, 2016 · CIK: 0000812796 · Accession: 0000000000-16-097309
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-214038
Letter
Mail Stop 4546 October 14, 2016 Christopher J. Schaber, Ph.D. President and Chief Executive Officer Soligenix, Inc. 29 Emmons Drive, Suite C -10 Princeton, New Jersey 08540
Re: Soligenix, Inc. Registration Statement on Form S-1 Filed October 7 , 2016 File No. 333-214038
Dear Dr. Schaber :
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Michael Gershon at (202) 551 -6598 or Mary Beth Breslin at (202) 551 - 3625 with a ny questions.
Sincerely,
/s/ Mary Beth Breslin for
Show Raw Text
Mail Stop 4546 October 14, 2016 Christopher J. Schaber, Ph.D. President and Chief Executive Officer Soligenix, Inc. 29 Emmons Drive, Suite C -10 Princeton, New Jersey 08540 Re: Soligenix, Inc. Registration Statement on Form S-1 Filed October 7 , 2016 File No. 333-214038 Dear Dr. Schaber : This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Michael Gershon at (202) 551 -6598 or Mary Beth Breslin at (202) 551 - 3625 with a ny questions. Sincerely, /s/ Mary Beth Breslin for Suzanne Hayes Assistant Director Office of Healthcare and Insurance cc: Leslie J. Croland, Esq.